WIM
DFTX

Westside Investment Management’s Definium Therapeutics DFTX Stock Holding History

Westside Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66
Closed -$376 – 1005
2024
Q3 		$376 Hold
66
– – ﹤0.01% 968
2024
Q2 		$476 Hold
66
– – ﹤0.01% 959
2024
Q1 		$620 Hold
66
– – ﹤0.01% 871
2023
Q4 		$242 Hold
66
– – ﹤0.01% 847
2023
Q3 		$207 Hold
66
– – ﹤0.01% 822
2023
Q2 		$236 Hold
66
– – ﹤0.01% 824
2023
Q1 		$209 Hold
66
– – ﹤0.01% 821
2022
Q4 		$0 Hold
66
– – ﹤0.01% 828
2022
Q3 		$0 Sell
66
-1
-1% -$10 ﹤0.01% 835
2022
Q2 		$0 Buy
+67
New +$848 ﹤0.01% 821
2022
Q1 		– Sell
-67
Closed -$1 – 799
2021
Q4 		$1 Hold
67
– – ﹤0.01% 758
2021
Q3 		$2 Buy
+67
New +$2.9K ﹤0.01% 722

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Westside Investment Management's DFTX Position: Q4 2024 in Review

Westside Investment Management sold out of Definium Therapeutics (DFTX) in Q4 2024, closing a stake of 66 shares — an estimated $376 sold.

Westside Investment Management first reported a position in DFTX in Q3 2021 and held it in 12 quarters. The position peaked at $620 in Q1 2024. 172 funds tracked by Wall St. Rank hold DFTX as of Q4 2024.

  • Westside Investment Management reported no remaining Definium Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Westside Investment Management sold 66 Definium Therapeutics shares in Q4 2024, an estimated $376.
  • Westside Investment Management first reported a position in Definium Therapeutics in Q3 2021 and held it in 12 quarters.
  • Westside Investment Management's Definium Therapeutics position peaked at $620 in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2024.

Based on Westside Investment Management's 13F filing for Q4 2024, filed 17 Jan 2025.